Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

SION – sionna therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SION
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
06:46 pm
sion
Form 4 Sionna Therapeutics, For: Nov 24 Filed by: ORBIMED ADVISORS LLC
Low Report
Form 4 Sionna Therapeutics, For: Nov 24 Filed by: ORBIMED ADVISORS LLC
Report
11/26
06:42 pm
sion
Form 4 Sionna Therapeutics, For: Nov 24 Filed by: Thompson Peter A.
Low Report
Form 4 Sionna Therapeutics, For: Nov 24 Filed by: Thompson Peter A.
Report
11/24
08:23 pm
sion
Form 144 Sionna Therapeutics, Filed by: ORBIMED ADVISORS LLC
Low Report
Form 144 Sionna Therapeutics, Filed by: ORBIMED ADVISORS LLC
Report
11/24
05:43 pm
sion
Form 4 Sionna Therapeutics, For: Nov 20 Filed by: RA Capital Nexus Fund, L.P.
Low Report
Form 4 Sionna Therapeutics, For: Nov 20 Filed by: RA Capital Nexus Fund, L.P.
Report
11/21
04:24 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Report
11/21
04:21 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Report
11/21
04:20 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Report
11/21
04:18 pm
sion
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Low Report
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Report
11/20
04:41 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
High Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Report
11/20
04:36 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
High Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Report
11/20
04:34 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
High Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Report
11/20
04:30 pm
sion
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
High Report
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Report
11/19
08:44 pm
sion
Form 4 Sionna Therapeutics, For: Nov 17 Filed by: RA Capital Healthcare Fund LP
Low Report
Form 4 Sionna Therapeutics, For: Nov 17 Filed by: RA Capital Healthcare Fund LP
Report
11/19
05:21 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Report
11/19
05:16 pm
sion
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Low Report
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Report
11/19
05:12 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Report
11/19
05:04 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Report
11/18
05:23 pm
sion
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Low Report
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Report
11/18
05:18 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Report
11/18
05:09 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Report
11/18
04:58 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Report
11/17
05:13 pm
sion
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Medium Report
Form 144 Sionna Therapeutics, Filed by: BLACKWELL PARTNERS LLC - SERIES A
Report
11/17
05:04 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Medium Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund, L.P.
Report
11/17
04:57 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Medium Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Nexus Fund III, L.P.
Report
11/17
04:47 pm
sion
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Low Report
Form 144 Sionna Therapeutics, Filed by: RA Capital Healthcare Fund LP
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0